Share on LinkedInShare on LinkedIn

ARTICLE · 20 JANUARY 2022

Patent Waiving Is Not The Solution To Enhance Access

Olivares
Olivares
Contributor
Olivares

Olivares

Our mission is to provide innovative solutions and highly specialized legal advice for clients...

View firm profile
Explore more from Olivares

Patent waiving for COVID-19 vaccines has been touted as a way to increase access to those jabs.

MexicoIntellectual Property

Q: Patent waiving for COVID-19 vaccines has been touted as a way to increase access to those jabs. How would such a measure impact global vaccination campaigns?

A: Patents are not responsible for the crisis or issues related to the mismanagement of health system. It is easy to say that patents are barriers but this is incorrect. The technology developed to create COVID-19 vaccines is very complex and is recognized through legal protection. Patent protection should not be used as the argument to blame lack of access, neither for COVID-19 vaccines nor for any other medical development. If anything, patents help innovation reach the market and foment further medical developments.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from